questionsmedicales.fr
Cellules
Structures cellulaires
Espace intracellulaire
Cytoplasme
Structures cytoplasmiques
Organites
Ribosomes
Polyribosomes
Polyribosomes : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Polyribosomes : Questions médicales les plus fréquentes",
"headline": "Polyribosomes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Polyribosomes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-06",
"dateModified": "2025-05-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Polyribosomes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Ribosomes",
"url": "https://questionsmedicales.fr/mesh/D012270",
"about": {
"@type": "MedicalCondition",
"name": "Ribosomes",
"code": {
"@type": "MedicalCode",
"code": "D012270",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.284.430.214.190.875.811"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Réticulum endoplasmique rugueux",
"alternateName": "Endoplasmic Reticulum, Rough",
"url": "https://questionsmedicales.fr/mesh/D018870",
"about": {
"@type": "MedicalCondition",
"name": "Réticulum endoplasmique rugueux",
"code": {
"@type": "MedicalCode",
"code": "D018870",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.284.430.214.190.875.811.740.300"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Polyribosomes",
"alternateName": "Polyribosomes",
"code": {
"@type": "MedicalCode",
"code": "D011132",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Timur N Baymukhametov",
"url": "https://questionsmedicales.fr/author/Timur%20N%20Baymukhametov",
"affiliation": {
"@type": "Organization",
"name": "Structural biology department, National Research Center 'Kurchatov Institute', Moscow 123182, Russia."
}
},
{
"@type": "Person",
"name": "Dmitry N Lyabin",
"url": "https://questionsmedicales.fr/author/Dmitry%20N%20Lyabin",
"affiliation": {
"@type": "Organization",
"name": "Institute of Protein Research RAS, Pushchino, Moscow Region 142290, Russia."
}
},
{
"@type": "Person",
"name": "Yury M Chesnokov",
"url": "https://questionsmedicales.fr/author/Yury%20M%20Chesnokov",
"affiliation": {
"@type": "Organization",
"name": "Probe and Electron Microscopy Resource Center, National Research Center 'Kurchatov Institute', Moscow 123182, Russia."
}
},
{
"@type": "Person",
"name": "Ivan I Sorokin",
"url": "https://questionsmedicales.fr/author/Ivan%20I%20Sorokin",
"affiliation": {
"@type": "Organization",
"name": "Institute of Protein Research RAS, Pushchino, Moscow Region 142290, Russia."
}
},
{
"@type": "Person",
"name": "Evgeniya V Pechnikova",
"url": "https://questionsmedicales.fr/author/Evgeniya%20V%20Pechnikova",
"affiliation": {
"@type": "Organization",
"name": "Probe and Electron Microscopy Resource Center, National Research Center 'Kurchatov Institute', Moscow 123182, Russia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Research data management needs assessment for social sciences graduate students: A mixed methods study.",
"datePublished": "2023-02-23",
"url": "https://questionsmedicales.fr/article/36821558",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0282152"
}
},
{
"@type": "ScholarlyArticle",
"name": "Generalized overview infographic: a customizable library instructional material on the NIH Data Management and Sharing Policy.",
"datePublished": "2024-05-22",
"url": "https://questionsmedicales.fr/article/39119172",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5195/jmla.2024.1867"
}
},
{
"@type": "ScholarlyArticle",
"name": "Bridging data management platforms and visualization tools to enable ad-hoc and smart analytics in life sciences.",
"datePublished": "2022-09-08",
"url": "https://questionsmedicales.fr/article/36073980",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1515/jib-2022-0031"
}
},
{
"@type": "ScholarlyArticle",
"name": "Web log mining techniques to optimize Apriori association rule algorithm in sports data information management.",
"datePublished": "2024-10-15",
"url": "https://questionsmedicales.fr/article/39406842",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-74427-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Data Management and Privacy Policy of COVID-19 Contact-Tracing Apps: Systematic Review and Content Analysis.",
"datePublished": "2022-07-12",
"url": "https://questionsmedicales.fr/article/35709334",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/35195"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures cellulaires",
"item": "https://questionsmedicales.fr/mesh/D022082"
},
{
"@type": "ListItem",
"position": 4,
"name": "Espace intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D042541"
},
{
"@type": "ListItem",
"position": 5,
"name": "Cytoplasme",
"item": "https://questionsmedicales.fr/mesh/D003593"
},
{
"@type": "ListItem",
"position": 6,
"name": "Structures cytoplasmiques",
"item": "https://questionsmedicales.fr/mesh/D022083"
},
{
"@type": "ListItem",
"position": 7,
"name": "Organites",
"item": "https://questionsmedicales.fr/mesh/D015388"
},
{
"@type": "ListItem",
"position": 8,
"name": "Ribosomes",
"item": "https://questionsmedicales.fr/mesh/D012270"
},
{
"@type": "ListItem",
"position": 9,
"name": "Polyribosomes",
"item": "https://questionsmedicales.fr/mesh/D011132"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Polyribosomes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Polyribosomes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Polyribosomes",
"description": "Comment détecte-t-on les polyribosomes ?\nQuels tests sont utilisés pour étudier les polyribosomes ?\nLes polyribosomes sont-ils visibles en microscopie optique ?\nPeut-on quantifier les polyribosomes ?\nLes polyribosomes sont-ils liés à des maladies ?",
"url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Data+Management&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Polyribosomes",
"description": "Quels symptômes sont liés aux dysfonctionnements des polyribosomes ?\nLes polyribosomes affectent-ils la croissance cellulaire ?\nY a-t-il des symptômes neurologiques associés ?\nLes polyribosomes influencent-ils le métabolisme ?\nPeut-on observer des symptômes immunitaires ?",
"url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Data+Management&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Polyribosomes",
"description": "Comment prévenir les dysfonctionnements des polyribosomes ?\nLes vaccinations influencent-elles les polyribosomes ?\nY a-t-il des facteurs environnementaux à surveiller ?\nL'exercice physique a-t-il un impact ?\nDes contrôles médicaux réguliers sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Data+Management&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Polyribosomes",
"description": "Comment traiter les dysfonctionnements des polyribosomes ?\nDes médicaments peuvent-ils affecter les polyribosomes ?\nY a-t-il des approches nutritionnelles ?\nLes thérapies géniques peuvent-elles aider ?\nDes traitements expérimentaux existent-ils ?",
"url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Data+Management&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Polyribosomes",
"description": "Quelles complications peuvent survenir avec des polyribosomes défectueux ?\nLes polyribosomes affectent-ils le cancer ?\nY a-t-il des risques de maladies neurodégénératives ?\nLes infections peuvent-elles aggraver les problèmes de polyribosomes ?\nDes troubles de croissance peuvent-ils survenir ?",
"url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Data+Management&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Polyribosomes",
"description": "Quels facteurs génétiques influencent les polyribosomes ?\nL'alimentation joue-t-elle un rôle ?\nLe stress oxydatif impacte-t-il les polyribosomes ?\nLes toxines environnementales sont-elles un risque ?\nLe vieillissement affecte-t-il les polyribosomes ?",
"url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Data+Management&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecte-t-on les polyribosomes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les polyribosomes sont généralement observés par microscopie électronique."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour étudier les polyribosomes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse par centrifugation et l'électrophorèse sur gel sont courantes."
}
},
{
"@type": "Question",
"name": "Les polyribosomes sont-ils visibles en microscopie optique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils nécessitent une microscopie électronique pour être visualisés."
}
},
{
"@type": "Question",
"name": "Peut-on quantifier les polyribosomes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, par des méthodes comme la spectrophotométrie et l'analyse d'images."
}
},
{
"@type": "Question",
"name": "Les polyribosomes sont-ils liés à des maladies ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans leur formation peuvent être associées à certaines pathologies."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés aux dysfonctionnements des polyribosomes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles de la synthèse protéique peuvent entraîner des symptômes variés."
}
},
{
"@type": "Question",
"name": "Les polyribosomes affectent-ils la croissance cellulaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une synthèse protéique altérée peut inhiber la croissance cellulaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles neurologiques peuvent survenir si la synthèse protéique est affectée."
}
},
{
"@type": "Question",
"name": "Les polyribosomes influencent-ils le métabolisme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils jouent un rôle clé dans le métabolisme cellulaire par la synthèse des protéines."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes immunitaires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies dans les polyribosomes peuvent affecter la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir les dysfonctionnements des polyribosomes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir ces dysfonctionnements."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles les polyribosomes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent améliorer la réponse immunitaire et la fonction des polyribosomes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à surveiller ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines peut affecter la fonction des polyribosomes."
}
},
{
"@type": "Question",
"name": "L'exercice physique a-t-il un impact ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la santé cellulaire et la fonction des polyribosomes."
}
},
{
"@type": "Question",
"name": "Des contrôles médicaux réguliers sont-ils nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans de santé réguliers peuvent aider à détecter des anomalies précocement."
}
},
{
"@type": "Question",
"name": "Comment traiter les dysfonctionnements des polyribosomes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la cause sous-jacente, souvent par des thérapies ciblées."
}
},
{
"@type": "Question",
"name": "Des médicaments peuvent-ils affecter les polyribosomes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent moduler la synthèse protéique via les polyribosomes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des approches nutritionnelles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une nutrition adéquate peut soutenir la synthèse protéique et la fonction des polyribosomes."
}
},
{
"@type": "Question",
"name": "Les thérapies géniques peuvent-elles aider ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent corriger des défauts génétiques affectant les polyribosomes."
}
},
{
"@type": "Question",
"name": "Des traitements expérimentaux existent-ils ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours sur des traitements ciblant les polyribosomes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des polyribosomes défectueux ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles métaboliques et des maladies dégénératives peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les polyribosomes affectent-ils le cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans leur fonction peuvent contribuer à la progression du cancer."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de maladies neurodégénératives ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dysfonctionnements des polyribosomes sont liés à des maladies comme Alzheimer."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles aggraver les problèmes de polyribosomes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent perturber la synthèse protéique via les polyribosomes."
}
},
{
"@type": "Question",
"name": "Des troubles de croissance peuvent-ils survenir ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans les polyribosomes peuvent entraîner des retards de croissance."
}
},
{
"@type": "Question",
"name": "Quels facteurs génétiques influencent les polyribosomes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mutations génétiques peuvent affecter la formation et la fonction des polyribosomes."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une carence en nutriments essentiels peut perturber la fonction des polyribosomes."
}
},
{
"@type": "Question",
"name": "Le stress oxydatif impacte-t-il les polyribosomes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut endommager les ribosomes et affecter leur fonction."
}
},
{
"@type": "Question",
"name": "Les toxines environnementales sont-elles un risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines peut nuire à la synthèse protéique via les polyribosomes."
}
},
{
"@type": "Question",
"name": "Le vieillissement affecte-t-il les polyribosomes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut entraîner une diminution de l'efficacité des polyribosomes."
}
}
]
}
]
}
The complexity and privacy issues inherent in social science research data makes research data management (RDM) an essential skill for future researchers. Data management training has not fully addres...
The Generalized Overview of the NIH Data Management and Sharing Policy Effective 2023.01.15 (Generalized Overview) is an instructional material that provides a basic, clear, and linear understanding o...
Core facilities have to offer technologies that best serve the needs of their users and provide them a competitive advantage in research. They have to set up and maintain instruments in the range of t...
To optimize the current college sports data information management system, this study combines the Apriori association rule algorithm with web application development technology to upgrade the managem...
COVID-19 digital contact-tracing apps were created to assist public health authorities in curbing the pandemic. These apps require users' permission to access specific functions on their mobile phones...
This study aimed to systematically map existing contact-tracing apps and evaluate the permissions required and their privacy policies. Specifically, we evaluated the type of permissions, the privacy p...
We used custom Google searches and existing lists of contact-tracing apps to identify potentially eligible apps between May 2020 and November 2021. We included contact-tracing or exposure notification...
We identified 180 contact-tracing apps across 152 countries, states, or territories. We included 85.6% (154/180) of apps with a working Google Play page, most of which (132/154, 85.7%) had a privacy p...
Many contact-tracing apps were developed covering most of the planet but with a relatively low number of installs. Privacy-preserving apps scored high in transparency and App Store ratings, suggesting...
We developed pISA-tree, a straightforward and flexible data management solution for organisation of life science project-associated research data and metadata. pISA-tree was initiated by end-user requ...
Clinical, time-dependent, therapeutic and diagnostic data of patients with LUTS are highly complex. To better manage these data for therapists' and researchers' we developed the application ShinyLUTS....
The statistical programming language R and the framework Shiny were used to develop a platform for data entry, monitoring of therapy and scientific data analysis. As part of a use case, ShinyLUTS was ...
The final database on patients with LUTS comprised a total of 8.118 time-dependent parameters in 11 data tables. Data entry, monitoring of therapy as well as data retrieval for scientific use, was dee...
The ShinyLUTs application presented here is suitable for collecting, archiving, and managing complex data on patients with LUTS. Aside from the implementation in a scientific workflow, it is suited fo...
A knowledge-based planning technique is developed based on Bayesian stochastic frontier analysis. A novel missing data management is applied in order to handle missing organs-at-risk and work with a c...
Geometric metrics are used to predict DVH metrics for lung SBRT with a retrospective database of 299 patients. In total, 16 DVH metrics were predicted for the main bronchus, heart, esophagus, spinal c...
Mean difference between the observed and predicted values ranges between 1.5 ± 1.9 Gy and 4.9 ± 5.3 Gy for the spinal cord PRV D0.35cc and the main bronchus D0.035cc, respectively....
The missing data model implanted in the predictive model is robust in the estimation of the parameters. Bayesian stochastic frontier analysis with missing data management can be used to predict DVH me...
The pharmaceutical industry continuously looks for ways to improve its development and manufacturing efficiency. In recent years, such efforts have been driven by the transition from batch to continuo...
The nomenclatures used to describe HLA and killer-cell immunoglobulin-like receptor (KIR) alleles distinguish unique nucleotide and peptide sequences, and patterns of expression, but are insufficient ...